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Abstract
Background: Open surgery is widely used as a benchmark for the results of fenestrated endovascular repair of complex
abdominal aortic aneurysms (AAA). However, the existing evidence stems from single-centre experiences, and may not be
reproducible in wider practice. National outcomes provide valuable information regarding the safety of suprarenal
aneurysm repair.
Methods: Demographic and clinical data were extracted from English Hospital Episodes Statistics for patients undergoing
elective suprarenal aneurysm repair from 1 April 2000 to 31 March 2010. Thirty-day mortality and five-year survival were
analysed by logistic regression and Cox proportional hazards modeling.
Results: 793 patients underwent surgery with 14% overall 30-day mortality, which did not improve over the study period.
Independent predictors of 30-day mortality included age, renal disease and previous myocardial infarction. 5-year survival
was independently reduced by age, renal disease, liver disease, chronic pulmonary disease, and known metastatic solid
tumour. There was significant regional variation in both 30-day mortality and 5-year survival after risk-adjustment. Regional
differences in outcome were eliminated in a sensitivity analysis for perioperative outcome, conducted by restricting analysis
to survivors of the first 30 days after surgery.
Conclusions: Elective suprarenal aneurysm repair was associated with considerable mortality and significant regional
variation across England. These data provide a benchmark to assess the efficacy of complex endovascular repair of supra-
renal aneurysms, though cautious interpretation is required due to the lack of information regarding aneurysm morphology.
More detailed study is required, ideally through the mandatory submission of data to a national registry of suprarenal
aneurysm repair.
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Introduction
Since its development in 1991 [1], endovascular aneurysm
repair (EVAR) has supplanted open repair (OR) as the most
common treatment for infrarenal abdominal aortic aneurysms
(AAA) in the UK [2] and USA [3]. This trend has been supported
by randomised controlled trials, which demonstrated that EVAR
was associated with considerably lower perioperative mortality
than OR and equivalence in long-term survival [4–7]. The
development of fenestrated (FEVAR) and branched devices has
extended the endovascular approach to patients with more
complex aneurysm morphology, with disease involving the renal
artery origins (suprarenal aneurysms) or coeliac and superior
mesenteric origins (Crawford type IV thoraco-abdominal aneu-
rysms). However, the technique is relatively novel and technically
challenging, while there remains uncertainty regarding the
optimum use of FEVAR in juxtarenal (JRA), suprarenal (SRA)
or type IV thoraco-abdominal (TAA) aneurysms [8]. Open
surgery provides an accepted standard of care for these patients,
and it has been suggested that the perioperative outcomes of open
surgery should therefore be used as a benchmark for FEVAR [9].
The technique of FEVAR can be applied to JRA, SRA, and
type IV TAA [10]. Outcomes of fenestrated aortic procedures
should therefore be compared to those following open repair of all
these types of aneurysm. Individual centres have reported that
open JRA repair can be performed with perioperative mortality as
low as 2.5–2.9% [9,11], while data from the American National
Surgical Quality Improvement Programme (NSQIP) suggested
that complex aneurysms, defined as those with visceral involve-
ment, can be repaired with similar mortality to infrarenal AAA
(5.7% vs. 5.1%, respectively) [12]. Others have noted that SRA or
type IV TAA repair was associated with significantly greater
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perioperative mortality than JRA repair (20% vs. 4.5%) [13,14].
The existing data for open complex aneurysm repair stem largely
from individual centres of excellence and are limited by small
sample sizes, the potential for publication bias, and a lack of
external validity. In contrast, administrative data provide an
unselected and representative record of national outcomes. An
epidemiological study of open suprarenal aneurysm repair in
England is of particular value as a counterpart for the results of the
GLOBALSTAR registry, which reported every FEVAR per-
formed in the UK between 2007 and 2010 [15] (including 3-vessel
or 4-vessel FEVAR SRA or type IV TAA). The present study
aimed to place these data in context, by reporting and analysing
the outcomes of open SRA repair during the same time period, in
the same healthcare system.
Methods
Demographic and in-hospital outcome data were extracted
from Hospital Episode Statistics for patients undergoing elective
open suprarenal aneurysm repair in England between 1 April
2000 and 31 March 2010. These data were linked to mortality
records from the Office of National Statistics (ONS) to track long-
term survival. The admission on which the procedure was
performed was termed the index admission for the purposes of
this study, and defined reporting standards were followed [16].
The HES are the administrative data set for the English National
Health Service (NHS), which contains information regarding
every admission of a patient to an NHS hospital. HES data are
pseudonymized by the allocation of a unique identifier to each
patient, so individuals can be tracked as their care moves from
consultant to consultant (episodes) on any particular admission and
between hospital admissions (spells). The data set therefore allows
individual patients to be followed with respect to multiple hospital
admissions. This feature is unique to the HES data over
administrative data sets from other countries, which do not have
a facility for long-term follow-up. The Office for National Statistics
(ONS) is an independent, executive office of the UK Statistics
Authority, which records the date of all deaths in the UK matched
to individual demographic data. This includes deaths both in and
out of hospital. The date of death of each patient recorded in the
Figure 1. Provision of suprarenal aneurysm repair in English hospitals from 2000–2010, compared to provision of infrarenal repair
during the same period.
doi:10.1371/journal.pone.0064163.g001
Table 1. Characteristics of patients undergoing suprarenal
aneurysm repair in England from 2000–2010.
Patient characteristic Mean (SD) or n(%)
Age 71.61 (7.11)
Gender 612 (77.18%) Male
181 (22.82%) Female
Comorbidity
Myocardial infarction 99 (12.48%)
Congestive cardiac failure 70 (8.83%)
Peripheral vascular disease 764 (96.34%)
Cerebrovascular disease 66 (8.32%)
Dementia 6 (0.76%)
Chronic pulmonary disease 147 (18.54%)
Rheumatological disease 18 (2.27%)
Liver disease 10 (1.26%)
Diabetes mellitus 71 (8.95%)
Hemiplegia or paraplegia 11 (1.39%)
Renal disease 120 (15.13%)
Any malignancy 94 (11.85%)
Metastatic solid tumour 12 (1.51%)
doi:10.1371/journal.pone.0064163.t001
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ONS registry is linked to the patient’s individual HES identifier.
This allowed long-term outcomes to be quantified for the present
cohort in terms of in- and out-of-hospital deaths. Each patient was
matched against ONS records to identify any recorded date of
death for 10 years following the index admission [17]. Owing to
the uncertainty regarding aortic-related deaths, as few patients
undergo autopsy in the UK, only all-cause mortality was reported
in this study.
Elective suprarenal aneurysm (SRA) repairs were identified
from the HES using in-house software as previously described
[2,18,19]. The inclusion criterion was defined as all patients with
an OPCS (Office of Procedures, Census and Surveys) procedural
code of L19.3 (‘‘Replacement of aneurysmal segment of suprarenal
abdominal aorta by anastomosis of aorta to aorta’’). A minimum
age of 50 years was used to exclude miscoded paediatric cases with
congenital aortic disease. Emergency admissions, urgent admis-
sions and patients with thoracic, infrarenal or ruptured aneurysms,
were excluded. Patients known to have undergone bypass, ligation,
endarterectomy, embolization, or ‘‘other operation on’’ visceral
branches of the abdominal aorta were excluded; in an attempt to
restrict the study inclusion criterion to true suprarenal aneurysms
without visceral segment involvement. However, a limitation of
this study was the lack of data or imaging regarding aneurysm
morphology, and the incorporation of some patients with
infrarenal AAA or type IV thoraco-abdominal aneurysms could
not be definitively guaranteed.
The primary outcome measure was in- and out-of-hospital all-
cause mortality at 30 days. The secondary outcome measures were
length of stay, and 5-year all-cause survival, with a sensitivity
analysis for the effect of the perioperative period on long-term
outcome performed by including and excluding those who
survived the first 30 days.
Statistical models were constructed to identify the relative
importance of demographic, geographic and comorbidity indica-
tors on these outcomes (both 30-day mortality and 5-year survival).
The modelling included data regarding each patient’s year of
surgery, the Strategic Health Authority in which the index
procedure was performed (SHA; ten geographical regions of
healthcare provision in the English National Heath Service)
patient demographics (age, gender and social deprivation index)
and comorbidity. An interaction term for SHA and social
deprivation was included in all statistical models, as there are
well-established geographical variations in social deprivation in the
UK, which tend to overlap with areas of poor healthcare outcomes
[20]. Co-morbidity was identified using individual components of
the Royal College of Surgeons Charlson score methodology for
administrative data [21], and categorised as prior myocardial
infarction, congestive cardiac failure, peripheral vascular disease,
cerebrovascular disease, chronic pulmonary disease, diabetes
mellitus, renal disease, dementia or previous malignancy. The
annual caseload (volume) of SRA repairs undertaken in each
hospital per year were incorporated in all models by grouping
hospitals into quintiles of caseload. The quintiles comprised five
groups of institutions, arranged by the number of SRA repairs
undertaken per year, each quintile containing a similar number of
patients. They were created to ensure that all hospitals of a
particular annual operative caseload were grouped together,
rather than splitting hospitals of the same annual volume to create
exactly the same number of patients in each quintile.
Statistical Analysis
All analyses were performed using SAS version 9.1 (SAS
Institute Inc., USA).
1. 30-day mortality. Multivariate analysis was performed
using a binary logistic regression model. A backward selection
procedure was used, incorporating variables significant in univar-
iate analysis at p,0.1. Inclusion in the model required a
significance level of a=0.1. Significant results were reported from
the model at a significance level of a=0.05.
2. 5-year survival (including and excluding 30-day
mortality). Kaplan-Meier analysis was used to report all-cause
survival. Subgroup comparison was performed by log-rank test,
with Sidak adjustment for multiple comparisons. Cox proportional
hazards models were fitted for analysis of survival, including
consideration of gender, age on index admission, quintiles of social
deprivation, strategic health authority (SHA), year of surgery, and
comorbidity. Backward and stepwise selection procedures were
used, with comparison of models by Akaike’s Information
Criterion (AIC) to ascertain whether individual covariates
improved goodness-of-fit. Inclusion in the model required a
significance level of a=0.1, and significant results were reported at
a=0.05.
3. Length of stay. For length of stay, multiple linear
regression was performed on the logarithm of the length of stay,
using a general linear model procedure. Type III (orthogonal) sum
of squares analyses were tested using the F-distribution, and the
effect of independent variables on length of stay was quantified
using regression estimates.
4. Comparison between different strategic health
authorities or between quintiles of social deprivation
index. Comparison of risk-adjusted outcomes was performed
by planned orthogonal contrasts between the ten SHAs, or
between the five quintiles of social deprivation index.
Results
793 SRA repairs were performed in England between 1 April
2000 and 31 March 2010. 609/793 (76.8%) patients were male,
with a mean6 s.d. age of 71.667.11 years. Mean6 s.d. follow-up
was 3.5262.90 years; and comorbidity was common with a history
of myocardial infarction in 99/793 (12.48%) cases, congestive
cardiac failure in 70/793 (8.83%), chronic obstructive pulmonary
disease in 147/793 (18.54%) and renal disease in 120/793
(15.13%) (Table 1). SRA repair was distributed unevenly amongst
UK trusts (Figure 1). 80% of all hospitals performing SRA repair
undertook less than one SRA repair per year over the study period
and 223/793 cases (28%) were recorded at 4 hospitals in
Newcastle, London (n= 2) and Bristol (Figure 1).
Thirty-day Mortality
Thirty-day mortality was 111/793 patients (14.0%). Age (OR
1.050, 95% CI 1.018–1.082, p= 0.0021), previous myocardial
infarction (OR 1.837, 95% CI 1.021–3.306, p = 0.0424), pre-
existing renal disease (OR 2.194, 95% CI 1.348–3.650,
p = 0.0017) and SHA (p= 0.0191) were independent predictors
of thirty-day mortality in logistic regression modelling. An
interaction term for SHA*social deprivation quintile was not
significant, and social deprivation was not a significant indepen-
dent predictor of thirty-day mortality. Two subgroups of SHAs
were identified through orthogonal contrasts analysis, with no
significant difference between the 30-day mortality of SHAs
contained within one subgroup. A significantly higher death rate
was associated with surgery in the subgroup containing North
East, North West, Yorkshire and the Humber and West Midlands
SHAs, compared to the subgroup containing East Midlands, East
of England, London, South East, South Central and South West
SHAs (OR=2.194, 95% CI 1.369–3.515) (Figure 2). There was
Open Suprarenal Aneurysm Repair in England
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Figure 2. Map to illustrate 30-day mortality after elective suprarenal aneurysm repair in different Strategic Health Authorities in
England between 2000–2010. Indicated cities contain the hospital performing most aneurysm repairs in each Strategic Health Authority.
doi:10.1371/journal.pone.0064163.g002
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no significant difference in 30-day mortality between each year of
surgery from 2000 to 2010 (Figure 3), or between quintiles of
hospital caseload (crude mortality rates were 10.3%, 9.1%, 16.7%,
22.7% and 15.5% in quintiles 1 to 5 respectively). A sensitivity
analysis for mortality in the largest 4 hospitals (according to
surgical caseload) also demonstrated no difference in 30-day
mortality (23/223 vs 88/570, p = 0.07).
Five-year Survival
Freedom from all-cause mortality was 78%, 73%, 67%, 63%
and 58% in years 1, 2, 3, 4 and 5 after surgery (Figure 4). The Cox
Proportional Hazards model for 5-year survival from the day of
surgery demonstrated that age (HR 1.03, 95% CI 1.01–1.05,
p = 0.0005), chronic obstructive pulmonary disease (HR 1.42, 95%
CI 1.07–1.88, p = 0.016), liver disease (HR 2.46, 95% CI 1.09–
5.59, p = 0.0310), renal disease (HR 1.80, 95% CI 1.34–2.41,
p,0.0001), metastatic solid tumour (HR 3.06, 95% CI 1.43–6.49,
p = 0.0038) and Strategic Health Authority (p = 0.0138) were
predictive of poor survival, with poorer 5-year survival in the
North East, North West, Yorkshire and West Midlands regions
than in the South East, South West or South Central regions
(Table 2) (Figure 5). An interaction term for SHA*social
deprivation quintile was not significant, and neither social
deprivation nor annual hospital SRA volume was a significant
independent predictor of five-year survival.
Five-year Survival in those Remaining Alive after the First
30 Postoperative Days
In patients surviving the first 30 postoperative days, freedom
from all-cause mortality was 91%, 86%, 78%, 73% and 68% in
years 1, 2, 3, 4 and 5 (Figure 6). The Cox Proportional Hazards
model for 5-year survival in this group demonstrated that age (HR
1.04, 95% CI 1.01–1.06, p = 0.0041), dementia (H.R. 8.55, 95%
CI 2.65–27.78, p= 0.0003), chronic obstructive pulmonary disease
(HR 1.93, 95% CI 1.37–2.73, p= 0.0002) liver disease (HR 3.83,
95% CI 1.18–12.50, p = 0.0253), renal disease (HR 1.63, 95% CI
1.10–2.42, p = 0.0158), metastatic solid tumour (HR 5.10 95% CI
2.28–11.36, p,0.0001) and social deprivation index (p= 0.0052)
were predictive of poor survival, with poorer 5-year survival in the
lowest two quintiles of social deprivation index (Table 3). There
was no significant interaction between social deprivation index
and SHA. SHA was not a significant independent predictor of 5-
year survival in those remaining alive after the first 30
postoperative days.
Length of Stay
Patients with peripheral vascular disease (p,0.0001) and
cerebrovascular disease (p = 0.0350) had a longer length of stay
than those without. SHA was also a significant predictor of length
of stay(p = 0.0350), presumably as a result of the demonstrated
difference in 30-day mortality.
Discussion
Open SRA repair in England was performed with considerably
greater mortality than has been reported for FEVAR in suprarenal
and complex aneurysms [15], with evidence of considerable
regional variation. Although it has been suggested that SRA repair
(with or without visceral revascularisation) can be performed with
equivalent safety to infrarenal AAA repair [12], the thirty-day
mortality of SRA repair in this study was considerably higher than
that reported for infrarenal AAA [2,18] or open JRA repair (2.9%)
[9] and was similar to the rate that has been reported by many
groups for the open repair of SRA and type IV TAA (5% to
22%)[13,22–27]. Detailed information regarding aneurysm mor-
phology was not available in the present study, and it is not
possible to definitively exclude the analysis of some cases involving
the visceral aorta in these results. The present study adds weight to
the argument that more proximal aneurysmal disease is associated
with greater perioperative mortality after open repair [13], with
the requirement for supravisceral clamping implicated in greater
Figure 3. 30-day mortality after suprarenal aneurysm repair in
England from 2000 to 2010, with 95% confidence intervals.
doi:10.1371/journal.pone.0064163.g003
Figure 4. Kaplan-Meier plot of all-cause survival after supra-
renal aneurysm repair in England from 2000 to 2010.
doi:10.1371/journal.pone.0064163.g004
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morbidity and mortality than a suprarenal aortic clamping [14].
After risk adjustment for comorbidity and demographics, the rate
of perioperative mortality did not improve over the study period
(Figure 3), despite assertions that developments in complex
aneurysm repair have increased its safety in recent years [26]
alongside evidence that increasingly elderly patients are being
treated for AAA in England [28].
It has been suggested that the results of open JRA repair should
be used to provide context for the performance of FEVAR [11],
but FEVAR can also be employed to treat the suprarenal and
visceral aorta. The present study therefore adds useful evidence to
the open surgical benchmark against which FEVAR must be
judged: it is important that the results of open surgery for SRA or
type IV TAA should be considered alongside the data for open
repair of JRA, to acknowledge the full range of disease that can be
treated by FEVAR. Patients undergoing open SRA repair, as
presented in this study, provide a useful comparative group for
patients who have undergone 3-vessel or 4-vessel FEVR, with
sealing zones above the superior mesenteric or coeliac artery.
Previous evidence describing open repair of SRA and type IV
TAA has been limited by small sample sizes, the inclusion of
symptomatic or ruptured cases alongside elective repairs, and
mixed cohorts of patients with JRA and SRA (despite differences
in the outcomes of surgery for JRA, SRA or type IV TAA) [26].
Administrative data, as provided by the present study, are of
particular value in reflecting surgical outcomes because single-
centre results are open to publication bias and can outperform
wider national practice [27]. The present study is of particular
value as a counterpart to the results of the BSET (British Society of
Endovascular Therapy) FEVAR registry, which reported that 318
FEVARs were performed in the UK between 2007 and 2010 with
4.1% perioperative mortality. The BSET investigators reported
that increasing the number of fenestrations for FEVAR led to
greater mortality, although this observation did not reach
statistical significance (a finding most likely explained by type II
error). Mortality was 2.7% after FEVAR with renal fenestrations
alone, and 2.9% for grafts with a superior mesenteric scallop/
fenestration. Mortality was 9.4% for FEVAR incorporating the
coeliac trunk; this subgroup is morphologically similar to
aneurysms treated by open SRA repair and the result can be
directly compared to the present study, where mortality was 14%.
Overall, the BSET results suggest that FEVAR compares
favourably with open SRA repair.
In the present study, increasing age, renal disease and previous
myocardial infarction were independent predictors of 30-day
mortality, which was consistent with existing evidence. Age and
renal function have previously been shown to exert an important
effect on perioperative outcome for SRA [12,13] and estimated
glomerular filtration rate (eGFR) in particular has been shown to
effect outcome in many atherosclerotic cardiovascular conditions
[29–31]. Renal function is important in SRA repair as the
requirement for suprarenal aortic clamping during the operation
imposes a period of renal hypoperfusion, which is less tolerated by
patients with pre-existing renal impairment. In this study ‘‘Renal
Disease’’ was defined according to the RCS Charlson index; a
validated tool that defines renal impairment (and other comor-
bidity) according to pre-specified administrative diagnostic codes.
Biochemical data such as eGFR would have provided a more
precise indicator of renal function but were not available in HES.
Predictors of long-term mortality included age, chronic
pulmonary disease, renal disease, liver disease and metastatic
solid tumour; after removal of the perioperative deaths, social
deprivation index replaced strategic health authority as a predictor
of long-term survival. These indicators represent potential areas
for targeted improvement of the 5-year outcome for patients with
repaired aneurysms, as despite recent evidence that aortic
aneurysm prevalence has fallen with improvements in public
Table 2. Significant covariates in Cox Proportional Hazards Model for 5-year survival from the day of elective open suprarenal
aneurysm repair.
Parameter Hazard Ratio 95% Confidence Limits p-value
Age on admission 1.03 1.01 1.05 0.0005
Chronic pulmonary disease 1.42 1.07 1.88 0.0160
Liver disease 2.46 1.09 5.59 0.0310
Renal disease 1.80 1.34 2.41 ,0.0001
Metastatic solid tumour 3.06 1.43 6.49 0.0038
Strategic Health Authority
North East vs South East 2.274 1.034 4.999 0.0138
North East vs South Central 2.499 1.239 5.041 0.0138
North East vs South West 1.743 1.037 2.929 0.0138
North West vs South East 2.346 1.073 5.129 0.0138
North West vs South Central 2.579 1.280 5.196 0.0138
North West vs South West 1.798 1.072 3.017 0.0138
Yorkshire and the Humber vs South East 2.266 1.043 4.924 0.0138
Yorkshire and the Humber vs South Central 2.491 1.251 4.959 0.0138
Yorkshire and the Humber vs South West 1.737 1.056 2.857 0.0138
West Midlands vs South East 2.478 1.130 5.435 0.0138
West Midlands vs South Central 2.724 1.353 5.481 0.0138
West Midlands vs South West 1.900 1.132 3.188 0.0138
doi:10.1371/journal.pone.0064163.t002
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Figure 5. Map to illustrate the odds ratio for 5-year risk-adjusted survival after elective suprarenal aneurysm repair in different
Strategic Health Authorities in England between 2000–2010, in relation to 5-year survival in London. Indicated cities contain the
hospital performing most aneurysm repairs in each Strategic Health Authority.
doi:10.1371/journal.pone.0064163.g005
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health [28,32], the fate of patients who survive SRA repair is
concerning.
There was a significant difference in mortality across different
geographical regions in England (Figure 2) after risk adjustment.
Similar regional variation was seen in five-year survival (Figure 5)
but was eliminated by restricting analysis to survivors of the first 30
postoperative days. This suggested that perioperative outcome was
of key importance in determining the long-term survival of
patients with SRA in different regions of England. The excellent
results of complex open aneurysm repair in Scotland have been
partly attributed to the concentration of national expertise in a
single centre [26], and the extent of regional variation observed in
the present study suggests that further data are required to inform
debate regarding the configuration of complex aneurysm surgery
in England, both in terms of regional variation and case volume.
Regional variation in risk-adjusted mortality has been demon-
strated for a range of disease conditions and cardiovascular
procedures in England [20]. The differing outcomes of SRA repair
in different SHAs was striking, but should be interpreted
cautiously given the limitations of this study. The worst outcomes
were seen in the North and Northwest regions of England; raising
the likelihood of incomplete risk adjustment for confounding
differences in underlying health. Social deprivation and analysis by
SHA may actually have been indices of a generally less healthy
population in the North of England, rather than variation in the
quality of SRA repair services. Inequalities in life expectancy
between the North and South of England have been well-
documented, with northern regions believed to fare poorly due to
a complex blend of socioeconomic, environmental, educational,
genetic and lifestyle factors [33]. Only one administrative index of
social deprivation was used for this study, and many other factors
may have been incompletely quantified, including smoking
behaviour, physical activity and cardiovascular risk prevention
therapies. A map of social deprivation in patients undergoing SRA
repair highlights the underlying ‘‘North-South divide’’ between
regions, with the anomaly that patients in London had greater
social deprivation than other southern SHAs (Figure 7). However,
after risk-adjustment there was no demonstrable statistical
interaction between SHA and social deprivation in this study.
Case volume was not a significant predictor of outcome in this
study, but there were a paucity of events for study in each volume
quintile and type II error cannot be excluded. Alongside the
inability to validate or adjust for differences in case mix, turndown
rates and variability in coding; the limited sample available for
study should prevent further inferences for or against further
regionalisation of SRA care from the present data sample. The
high overall mortality seen in this study is concerning, but might
reflect the inclusion of type IV thoracoabdominal TAAAs
alongside true SRAs. Confounding may also have been introduced
by differences in regional coding, and the major limitations of this
study relate to the nature of the Hospital Episode Statistics (HES)
dataset. Operative detail was restricted by the use of OPCS-4
procedure codes in HES and it was not possible to obtain more
precise data regarding the location of the aortic cross-clamp or
aneurysm morphology from CT aortograms, to more precisely
understand the types of aneurysm treated. OPCS-4 procedural
Figure 6. Kaplan-Meier plot of all-cause mortality in survivors
of the first 30 days after suprarenal aneurysm repair.
doi:10.1371/journal.pone.0064163.g006
Table 3. Significant covariates in Cox Proportional Hazards Model for 5-year survival in survivors of the first 30 days after elective
open suprarenal aneurysm repair.
Parameter Hazard Ratio 95% Confidence Limits p-value
Age on admission 1.035 1.011 1.059 0.0041
Dementia 8.55 2.65 27.78 0.0003
Chronic pulmonary disease 1.93 1.37 2.73 0.0002
Liver disease 3.83 1.18 12.50 0.0253
Renal disease 1.63 1.10 2.42 0.0158
Metastatic solid tumour 5.10 2.28 11.36 ,.0001
Social Deprivation Index Quintiles
1 vs 3 1.862 1.135 3.054 0.0052
1 vs 5 2.278 1.381 3.756 0.0052
2 vs 3 1.652 1.011 2.698 0.0052
2 vs 5 2.021 1.232 3.315 0.0052
doi:10.1371/journal.pone.0064163.t003
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Figure 7. Map to illustrate mean social deprivation index of patients undergoing elective suprarenal aneurysm repair in different
English Strategic Health Authorities.
doi:10.1371/journal.pone.0064163.g007
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codes used in the HES describe elective aneurysm repair for the
infrarenal aorta (L19.4), suprarenal aorta (L19.3), thoracic aorta
(L19.2) or ascending aorta (L19.1); there are no codes to indicate
thoraco-abdominal aneurysms or classify these by Crawford
subgroups. The present series is therefore likely to include both
SRA and type IV TAA, which may explain the higher mortality
observed in comparison to previous data combining JRA with
SRA. Although this limits the usefulness of the present study as a
specific reflection of SRA repair in distinction from type IV TAA
repair, the combined data remain important as a benchmark
against which 3-vessel and 4-vessel FEVAR can be judged.
The present study suggests that outcomes from open SRA
repair in England may have scope for improvement, and are
notably worse than national results for open infrarenal AAA
repair. The data are supportive of the continuing development of
FEVAR in specialist centres. In parallel, more detailed examina-
tion of open SRA repair is required in England, and a national
registry incorporating detailed morphological and procedural data
would allow further instructive comparison with the national
FEVAR registry (GLOBALSTAR). The infrastructure for data
collection already exists in the UK through the National Vascular
Database [34], which could be readily modified for this purpose.
Conclusion
This study of national outcomes across England demonstrates
relatively high mortality after elective open suprarenal aneurysm
repair, with significant regional variation in perioperative and
longer-term survival. These data are useful as a benchmark for the
comparison of national outcomes from 3-vessel or 4-vessel
FEVAR. The outcomes of open suprarenal aneurysm repair in
England require closer scrutiny, ideally through the mandatory
submission of all referrals (both operated and unoperated) to a
national registry reporting details of patient characteristics,
operative technique, and aneurysm complexity.
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